Funded Tech Companies
aFraxis
aFraxis, based in La Jolla, was acquired by Genentech.
Company Overview
Company Name
aFraxis
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
11099 N Torrey Pines Rd. 290
La Jolla, CA 92037
USA
La Jolla, CA 92037
USA
Phone
Website
Email Address
Company Background Information
Overview
Afraxis is discovering and developing drugs to treat diseases of the central nervous system, including schizophrenia, Alzheimer's disease, Fragile X syndrome and autism spectrum disorders. Recent scientific discoveries have linked these disorders to underlying defects in the development and function of specialized structures of the neural synapse, called dendritic spines.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/31/2013
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jay Lichter
Chief Scientific Officer
David Campbell
VP - Bus. Development
Carmine Stengone
VP - R & D
Christopher Rex
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs